Hc2 Holdings Inc (HCHC)

3.68  +0.02 (+0.55%)

After market: 3.68 0 (0%)

Fundamental Rating

1

Taking everything into account, HCHC scores 1 out of 10 in our fundamental rating. HCHC was compared to 41 industry peers in the Construction & Engineering industry. Both the profitability and financial health of HCHC have multiple concerns. HCHC is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

HCHC had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.47%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 0.5%
PM (TTM) -3.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for HCHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

HCHC has an Altman-Z score of 0.16. This is a bad value and indicates that HCHC is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.19 is on the high side and indicates that HCHC has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

HCHC has a Current Ratio of 1.10. This is a normal value and indicates that HCHC is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.10 indicates that HCHC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.53% over the past year.
HCHC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.51%.
HCHC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.14% yearly.
EPS 1Y (TTM)25.53%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-211.54%
Revenue 1Y (TTM)-43.51%
Revenue growth 3Y-14.94%
Revenue growth 5Y-2.14%
Revenue growth Q2Q-35.33%

3.2 Future

The Earnings Per Share is expected to grow by 32.00% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -40.49% on average over the next years. This is quite bad
EPS Next Y99.36%
EPS Next 2Y51.66%
EPS Next 3Y32%
EPS Next 5YN/A
Revenue Next Year42.23%
Revenue Next 2Y-46.63%
Revenue Next 3Y-40.49%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCHC. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 12.27, HCHC is valued correctly.
HCHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.72.
Industry RankSector Rank
PE N/A
Fwd PE 12.27

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.54

4.3 Compensation for Growth

HCHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HCHC's earnings are expected to grow with 32.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.66%
EPS Next 3Y32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HCHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Hc2 Holdings Inc

NYSE:HCHC (9/17/2021, 7:04:00 PM)

After market: 3.68 0 (0%)

3.68

+0.02 (+0.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap286.38M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.27
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.47%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 0.5%
PM (TTM) -3.1%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)25.53%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y99.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-43.51%
Revenue growth 3Y-14.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y